BIOPHARMA CREDIT PLC ORD USD0.0 - stock earnings
BPCR.L Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q2 | 35.5 million USD | 39.3 million USD |
2023Q1 | 35.5 million USD | 39.3 million USD |
2022Q4 | 57.1 million USD | 71.1 million USD |
2022Q3 | 57.1 million USD | 71.1 million USD |
2022Q2 | 34.1 million USD | 38.0 million USD |
2022Q1 | 34.1 million USD | 38.0 million USD |
2021Q2 | 44.2 million USD | 52.0 million USD |
2020Q4 | 48.8 million USD | 61.7 million USD |
2020Q2 | 40.4 million USD | 48.3 million USD |
2019Q4 | 42.4 million USD | 64.1 million USD |
2019Q2 | 30.6 million USD | 31.0 million USD |
2019Q1 | 30.6 million USD | 31.0 million USD |
2018Q4 | 17.5 million USD | 27.6 million USD |
2018Q3 | 17.5 million USD | 27.6 million USD |
2018Q2 | 17.5 million USD | 19.7 million USD |
2018Q1 | 17.5 million USD | 19.7 million USD |
2017Q2 | 7.1 million USD | 9.7 million USD |
BPCR.L Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2022 | 182.3 million USD | 184.2 million USD |
2021 | 85.0 million USD | 88.0 million USD |
2020 | 89.1 million USD | 91.4 million USD |
2019 | 122.3 million USD | 124.1 million USD |
2018 | 70.1 million USD | 78.7 million USD |
2017 | 31.7 million USD | 39.3 million USD |
BPCR.L
Price: $0.85
Dividend Yield: 0.08%
Forward Dividend Yield: 9.46%
Payout Ratio: 61.54%
Dividend Per Share: 0.08 USD
Earnings Per Share: 0.13 USD
P/E Ratio: 7.15
Exchange: LSE
Sector: Financial Services
Industry: Asset Management
Market Capitalization: 10.7 million
Average Dividend Frequency: 4
Years Paying Dividends: 8
DGR3: 17.33%
DGR5: 17.60%